ifosfamide has been researched along with Atypical Lipomatous Tumor in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the safety and efficacy of trabectedin in a phase II, open-label, multicenter, randomized study in adult patients with unresectable/metastatic liposarcoma or leiomyosarcoma after failure of prior conventional chemotherapy including anthracyclines and ifosfamide." | 9.14 | Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. ( Baker, LH; Blay, JY; Chawla, SP; Demetri, GD; Elsayed, YA; Gómez, J; Hande, KR; Izquierdo, MA; Keohan, ML; Le Cesne, A; Lebedinsky, C; Park, YC; Ritch, P; Samuels, BL; Schuetze, S; von Mehren, M, 2009) |
| " The final diagnosis was liposarcoma(myxoid type), and 5 courses of adjuvant chemotherapy with adriamycin and ifosfamide were performed." | 7.77 | [A case of huge omental-origin liposarcoma controlled by a combination of ifosfamide and adriamycin]. ( Hosono, T; Kawamura, M; Kawamura, T; Murakami, K; Noguchi, T; Sasaki, K; Sato, R, 2011) |
| "To assess the impact of different factors on response rate (RR), time to tumor progression (TTP), and overall survival time (OS) in patients with locally advanced or metastatic soft tissue sarcoma (ASTS), included in three protocols with high-dose ifosfamide (HDIF)." | 7.72 | Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS). ( Balañá, C; Buesa, J; Casado, A; de Las Peñas, R; del Muro, XG; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Quintana, MJ, 2004) |
| "We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 7.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
| "Primary mesenteric liposarcoma is a rare entity that has been reported only 14 times in English literature." | 5.33 | A case of resected huge ileocolonic mesenteric liposarcoma which responded to pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide. ( Chuman, H; Ishiguro, S; Moriya, Y; Yamamoto, S, 2006) |
| "To evaluate the safety and efficacy of trabectedin in a phase II, open-label, multicenter, randomized study in adult patients with unresectable/metastatic liposarcoma or leiomyosarcoma after failure of prior conventional chemotherapy including anthracyclines and ifosfamide." | 5.14 | Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. ( Baker, LH; Blay, JY; Chawla, SP; Demetri, GD; Elsayed, YA; Gómez, J; Hande, KR; Izquierdo, MA; Keohan, ML; Le Cesne, A; Lebedinsky, C; Park, YC; Ritch, P; Samuels, BL; Schuetze, S; von Mehren, M, 2009) |
| " Therefore, gemcitabine should be considered as the best option after doxorubicin failure in leiomyosarcoma patients." | 4.86 | [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. ( Bui-Nguyen, B; Italiano, A; Toulmonde, M, 2010) |
| "We report a case of a 61-year-old Asian man with metastatic retroperitoneal liposarcoma who was HBcAb positive and was treated with ifosfamide and dacarbazine, developed HBV reactivation secondary to ifosfamide requiring treatment with tenofovir." | 3.83 | Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma. ( Chaudhry, R; Cheedella, NK; Chhibar, P; Wang, JC; Zhu, Z, 2016) |
| " The final diagnosis was liposarcoma(myxoid type), and 5 courses of adjuvant chemotherapy with adriamycin and ifosfamide were performed." | 3.77 | [A case of huge omental-origin liposarcoma controlled by a combination of ifosfamide and adriamycin]. ( Hosono, T; Kawamura, M; Kawamura, T; Murakami, K; Noguchi, T; Sasaki, K; Sato, R, 2011) |
| "We report a case of postoperative recurrence of liposarcoma of the mesenterium successfully treated by chemotherapy using ifosfamide (IFM) and cisplatin (CDDP)." | 3.73 | [A case of liposarcoma of the sigmoid colon mesenterium successfully treated with chemotherapy]. ( Aoki, T; Kondo, M; Mizumura, Y; Moritani, M; Sasaki, Y; Tsuchida, A; Wada, T; Yamamoto, K, 2006) |
| "To assess the impact of different factors on response rate (RR), time to tumor progression (TTP), and overall survival time (OS) in patients with locally advanced or metastatic soft tissue sarcoma (ASTS), included in three protocols with high-dose ifosfamide (HDIF)." | 3.72 | Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS). ( Balañá, C; Buesa, J; Casado, A; de Las Peñas, R; del Muro, XG; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Quintana, MJ, 2004) |
| "We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 3.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
| "Liposarcoma is very rare in female genital tract, and more rare for dedifferentiated liposarcoma in gynecologic field." | 1.62 | Primary dedifferentiated Liposarcoma of vagina: a first case report. ( Shen, Y; Xie, C, 2021) |
| "On multivariate analysis, metastasectomy and objective response or stable disease achieved with first-line chemotherapy were indicators for better overall survival." | 1.51 | Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center. ( Cornillie, J; Debiec-Rychter, M; Hompes, D; Langmans, C; Schöffski, P; Sciot, R; van Cann, T; Vandenbempt, I; Wozniak, A, 2019) |
| "Primary mesenteric liposarcoma is a rare entity that has been reported only 14 times in English literature." | 1.33 | A case of resected huge ileocolonic mesenteric liposarcoma which responded to pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide. ( Chuman, H; Ishiguro, S; Moriya, Y; Yamamoto, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Nakahashi, K | 1 |
| Yokoyama, Y | 1 |
| Fukaya, M | 1 |
| Igami, T | 1 |
| Mizuno, T | 1 |
| Yamaguchi, J | 1 |
| Onoe, S | 1 |
| Watanabe, N | 1 |
| Ebata, T | 1 |
| Stacchiotti, S | 1 |
| Van der Graaf, WTA | 1 |
| Sanfilippo, RG | 1 |
| Marreaud, SI | 1 |
| Van Houdt, WJ | 1 |
| Judson, IR | 1 |
| Gronchi, A | 1 |
| Gelderblom, H | 1 |
| Litiere, S | 1 |
| Kasper, B | 1 |
| Schöffski, P | 2 |
| Blay, JY | 3 |
| Xie, C | 1 |
| Shen, Y | 1 |
| Setola, E | 1 |
| Noujaim, J | 1 |
| Benson, C | 1 |
| Chawla, S | 1 |
| Palmerini, E | 1 |
| Jones, RL | 1 |
| Tatenuma, T | 1 |
| Mizuno, N | 1 |
| Jikuya, R | 1 |
| Hashizume, A | 1 |
| Yasui, M | 1 |
| Umemoto, S | 1 |
| Kawai, M | 1 |
| Hiruma, T | 1 |
| Kishida, T | 1 |
| Langmans, C | 1 |
| Cornillie, J | 1 |
| van Cann, T | 1 |
| Wozniak, A | 1 |
| Hompes, D | 1 |
| Sciot, R | 1 |
| Debiec-Rychter, M | 1 |
| Vandenbempt, I | 1 |
| Chhibar, P | 1 |
| Zhu, Z | 1 |
| Cheedella, NK | 1 |
| Chaudhry, R | 1 |
| Wang, JC | 1 |
| Fayette, J | 1 |
| Penel, N | 1 |
| Chevreau, C | 1 |
| Cupissol, D | 1 |
| Thyss, A | 1 |
| Guillemet, C | 1 |
| Rios, M | 1 |
| Rolland, F | 1 |
| Fargeot, P | 1 |
| Bay, JO | 1 |
| Mathoulin-Pelissier, S | 1 |
| Coindre, JM | 1 |
| Bui-Nguyen, B | 2 |
| Berry, MF | 1 |
| Sporn, TA | 1 |
| Moore, JO | 1 |
| D'Amico, TA | 1 |
| Demetri, GD | 1 |
| Chawla, SP | 1 |
| von Mehren, M | 1 |
| Ritch, P | 1 |
| Baker, LH | 1 |
| Hande, KR | 1 |
| Keohan, ML | 1 |
| Samuels, BL | 1 |
| Schuetze, S | 1 |
| Lebedinsky, C | 1 |
| Elsayed, YA | 1 |
| Izquierdo, MA | 1 |
| Gómez, J | 1 |
| Park, YC | 1 |
| Le Cesne, A | 1 |
| Yokoi, M | 1 |
| Hosokawa, K | 1 |
| Funaki, H | 1 |
| Yoshitani, S | 1 |
| Kinami, S | 1 |
| Omote, K | 1 |
| Ueda, N | 1 |
| Nakano, Y | 1 |
| Kosaka, T | 1 |
| Minato, H | 1 |
| Macmull, S | 1 |
| Atkinson, HD | 1 |
| Saso, S | 1 |
| Tirabosco, R | 1 |
| O'Donnell, P | 1 |
| Skinner, JA | 1 |
| Italiano, A | 1 |
| Toulmonde, M | 1 |
| Noguchi, T | 1 |
| Kawamura, M | 1 |
| Kawamura, T | 1 |
| Sasaki, K | 1 |
| Hosono, T | 1 |
| Sato, R | 1 |
| Murakami, K | 1 |
| Eilber, FC | 1 |
| Eilber, FR | 1 |
| Eckardt, J | 1 |
| Rosen, G | 1 |
| Riedel, E | 1 |
| Maki, RG | 1 |
| Brennan, MF | 1 |
| Singer, S | 1 |
| Maurel, J | 1 |
| Buesa, J | 1 |
| López-Pousa, A | 1 |
| del Muro, XG | 1 |
| Quintana, MJ | 1 |
| Martín, J | 1 |
| Casado, A | 1 |
| Martínez-Trufero, J | 1 |
| de Las Peñas, R | 1 |
| Balañá, C | 1 |
| Sasaki, Y | 1 |
| Moritani, M | 1 |
| Wada, T | 1 |
| Mizumura, Y | 1 |
| Kondo, M | 1 |
| Yamamoto, K | 1 |
| Tsuchida, A | 1 |
| Aoki, T | 1 |
| Ishiguro, S | 1 |
| Yamamoto, S | 1 |
| Chuman, H | 1 |
| Moriya, Y | 1 |
| Izquierdo, R | 1 |
| Leinung, M | 1 |
| Fujinami, K | 1 |
| Kondoh, K | 1 |
| Kondoh, I | 1 |
| Miura, T | 1 |
| Kushida, K | 1 |
| Boven, E | 1 |
| Calame, JJ | 1 |
| Molthoff, CF | 1 |
| Pinedo, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trabectedin in Soft Tissue Sarcomas. A Retrospective Observational Analysis (TrObs)[NCT02793050] | 510 participants (Actual) | Observational | 2016-06-15 | Completed | |||
| ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)[NCT02194231] | Phase 2 | 145 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| A Randomized Phase II Trial Comparing the Activity of trabectedIn vs Gemcitabine in Patients With Metastatic or Locally Advanced Leiomyosarcoma Pretreated With Conventional Chemotherapy[NCT04383119] | Phase 2 | 100 participants (Anticipated) | Interventional | 2021-10-29 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma.
Topics: Doxorubicin; Humans; Ifosfamide; Liposarcoma; Sarcoma; Trabectedin | 2022 |
Eribulin in advanced liposarcoma and leiomyosarcoma.
Topics: Animals; Antineoplastic Agents; Doxorubicin; Furans; Humans; Ifosfamide; Ketones; Leiomyosarcoma; Li | 2017 |
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Docetaxel; Doxorubicin; Gemcitabine; Hu | 2010 |
2 trials available for ifosfamide and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, | 2009 |
18 other studies available for ifosfamide and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy.
Topics: Humans; Ifosfamide; Liposarcoma; Male; Middle Aged; Retroperitoneal Neoplasms; Survivors | 2022 |
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2022 |
Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Doxo | 2019 |
Primary dedifferentiated Liposarcoma of vagina: a first case report.
Topics: Adult; Antineoplastic Agents; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Female; | 2021 |
[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etopo | 2018 |
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.
Topics: Adult; Aged; Antineoplastic Agents; Disease Progression; Doxorubicin; Female; Humans; Ifosfamide; Li | 2019 |
Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma.
Topics: Antineoplastic Agents, Alkylating; Hepatitis B virus; Humans; Ifosfamide; Liposarcoma; Male; Middle | 2016 |
Giant thoracic liposarcoma treated with induction chemotherapy followed by surgical resection.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Human | 2009 |
[A case of retroperitoneal dedifferentiated liposarcoma successfully treated with IFM and CDDP].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Proto | 2009 |
Primary intra-osseous liposarcoma of the femur: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; | 2009 |
[A case of huge omental-origin liposarcoma controlled by a combination of ifosfamide and adriamycin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fatal Outcom | 2011 |
The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 2004 |
Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Bias; Clinical Trials, | 2004 |
[A case of liposarcoma of the sigmoid colon mesenterium successfully treated with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colon, Sigmoid; Drug Administration Sched | 2006 |
A case of resected huge ileocolonic mesenteric liposarcoma which responded to pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration S | 2006 |
Hyponatraemia secondary to administration of ifosfamide.
Topics: Aged; Female; Head and Neck Neoplasms; Humans; Hyponatremia; Ifosfamide; Liposarcoma | 1993 |
[A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 1999 |
Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.
Topics: Animals; Cyclophosphamide; Doxorubicin; Female; Fibrosarcoma; Histiocytoma, Benign Fibrous; Humans; | 1989 |